|Articles|July 25, 2022
Osmolality monitoring for UF/DF and CEX capture of mAbs from mammalian cell cultures
Author(s)Advanced Instruments
The goal of this paper is to introduce and support the use of osmolality in the Downstream Ultrafiltration/Diafiltration (UF/DF) process steps in the mAb workflow.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Analytics, Automation, and Quality Driving the Next Era of Drug Development
2
Trends in Formulation eBook October 2025
3
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
4
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
5
